New pill for arthritis passes first safety check in japanese men
NCT ID NCT05858788
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 32 times
Summary
This early-stage study tested a new oral drug, SAR441566, in 10 healthy Japanese men to see how the body processes it and if it is safe. The drug is being developed to help control rheumatoid arthritis, an autoimmune disease that causes joint pain and swelling. Since this is a phase 1 trial focused on safety and dosing, it does not yet test if the drug works for patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parexel International-Site Number:8400001
Glendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.